Home > Financial Ratios > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 26.6019.6619.3818.6216.82

What is the latest EV/Core EBITDA ratio of TORRENT PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of TORRENT PHARMACEUTICALS is 26.60 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202426.60
Mar202319.66
Mar202219.38
Mar202118.62
Mar202016.82

How is EV/Core EBITDA of TORRENT PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 26.6
35.30
Mar2023 19.66
1.44
Mar2022 19.38
4.08
Mar2021 18.62
10.70
Mar2020 16.82 -

Other Financial Ratios of TORRENT PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹109,458.9 Cr 0.1% 7.2% 25.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,393.0 Cr -3% 5.6% 9.3% Stock Analytics
DIVIS LABORATORIES ₹153,258.0 Cr 1% 2.7% 70.3% Stock Analytics
CIPLA ₹116,434.0 Cr -2.7% 0.4% -0.4% Stock Analytics
MANKIND PHARMA ₹99,974.0 Cr 2% 7.1% 8.8% Stock Analytics
DR REDDYS LABORATORIES ₹95,465.9 Cr -3.1% -0.2% -6.2% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

0.1%

7.2%

25.7%

SENSEX

1.7%

3.1%

6.8%


You may also like the below Video Courses